About us
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
The GA4GH Council, consisting of the Executive Committee, Strategic Leadership Committee, and Product Steering Committee, guides our collaborative, globe-spanning alliance.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across a number of Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
Find out what’s happening with up to the minute meeting schedules for the GA4GH community.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Want to advance both your career and responsible genomic data sharing at the same time? See our open leadership opportunities.
Join our international team and help us advance genomic data use for the benefit of human health.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
29 Oct 2024
International leaders in genomics, including members of the Global Alliance for Genomics and Health (GA4GH) community, call for the scaling of research and clinical genomic data sharing.
International leaders in genomics, including members of the Global Alliance for Genomics and Health (GA4GH) community, published “A call to action to scale up research and clinical genomic data sharing” in Nature Reviews Genetics on 7 October 2024.
The publication — led by representatives of GA4GH, Australian Genomics, Genomics England, the National Health Service (NHS) Genomic Medicine Service, All of Us Research Program, UK Biobank, and Our Future Health — emphasises the need to scale global genomic data sharing to enhance research and clinical outcomes in precision medicine.
The authors write, “We can and must do more to enable genomic data sharing…All of us, as funders, policymakers, health system leaders and members of the genomic data community and global genomics ecosystem, have a responsibility to act.”
Successful examples of data sharing, which have already had profound impact on the ability to accurately interpret genomic data in the research and clinical settings, include the Genome Aggregation Database (gnomAD), ClinVar, the Matchmaker Exchange, and the Gene Curation Coalition.
Even with these examples, there are still significant barriers to health data sharing that need to be overcome, including those that are technical and legal, in addition to those related to public trust and policy.
“Millions of people choose to donate their health-related data to help others,” said David Glazer, Workbench Chief Technology Officer at Verily. “We in the research community can honour their choice by supporting wide data sharing to fuel as many discoveries as possible and wise data sharing to ensure data is used as intended. Modern cloud-based environments make both possible, by providing secure and scalable environments for turning data into insights.”
The authors describe different data storage and analysis models and their impact on responsible data sharing. Many datasets are siloed at institutions around the world, others are stored in the cloud but require download to local infrastructure for analysis, while emerging data visiting approaches allow researchers to do their analysis in secure cloud-based environments.
These technical differences, concerns over data privacy, and international regulations limit data sharing, especially across borders. Federated approaches that bridge across multiple systems and interfaces can support researchers in appropriately accessing all available data for certain types of analysis.
GA4GH is working to develop a harmonised suite of tools and standards that facilitate responsible data sharing and support the entire lifecycle of data — from patient consent to data access, use, and exchange.
Zornitza Stark, Clinical Lead of Australian Genomics said, “With genomic data now increasingly generated as part of mainstream healthcare, we need to focus on extending the benefits of data sharing to patients undergoing clinical testing. This is absolutely key to improving the speed and accuracy of diagnosis but requires careful attention to the development of appropriate clinical consent and data management infrastructure.”
The authors conclude their article by proposing twelve actions (summarised in the graphic below) that all those involved in the genomics ecosystem can take to address the challenges associated with genomic data sharing. Development of genomic data sharing standards and infrastructure should foster inclusive participation by diverse communities to ensure that the benefits of genomic medicine are realised by all.
“Progress is dependent on investment in digital infrastructure, creation of incentives, and action from all of those engaged in providing care and doing research,” explained Richard Scott, Chief Executive Officer of Genomics England. “It also means we need to listen to patients and research participants and engage them as we co-design our solutions and studies. Historically, it has often been easier to focus on work that can be done at one institution, alone. This doesn’t cut it in genomics — to achieve the benefits that patients and participants are looking for, we need to work at a much greater scale.”